FUNI (Hypha Labs) Common Stock: $0.16 Mil (As of Mar. 2026)


What is Hypha Labs Common Stock?

Hypha Labs FUNI +9.59% Common Stock is $0.16 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Hypha Labs's quarterly common stock increased from Sep. 2025 ($0.15 Mil) to Dec. 2025 ($0.16 Mil) and increased from Dec. 2025 ($0.16 Mil) to Mar. 2026 ($0.16 Mil).

Hypha Labs's annual common stock increased from Sep. 2023 ($0.09 Mil) to Sep. 2024 ($0.12 Mil) and increased from Sep. 2024 ($0.12 Mil) to Sep. 2025 ($0.15 Mil).

Hypha Labs Common Stock Historical Data

* Premium members only.

The historical data trend for Hypha Labs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs Common Stock Chart

Hypha Labs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.08 0.09 0.12 0.15

Hypha Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.15 0.15 0.16 0.16

Hypha Labs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.16 Mil mean?
Hypha Labs (FUNI) has a Common Stock of $0.16 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Hypha Labs and its competitors.
Is Hypha Labs' Common Stock too high?
Hypha Labs' current Common Stock is $0.16 Mil.
How does Hypha Labs' Common Stock compare to IVRO and IDTA?
Hypha Labs' Common Stock of $0.16 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Hypha Labs and its competitors. Hypha Labs's current Common Stock is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current Common Stock of $0.16 Mil. The current Common Stock is $0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Hypha Labs (FUNI), the current Common Stock is $0.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.